Pharmaron Beijing Co., Ltd. logo

Pharmaron Beijing Co., Ltd. (3759)

Market Open
11 Aug, 08:00
HKEX HKEX
29. 22
HKD
+1.76
+6.4093%
HKD
- Market Cap
- P/E Ratio
0.09% Div Yield
24.39M Volume
0 Eps
27.46 HKD
Previous Close
Add Transaction
Day Range
27.18 30.68
Year Range
14.45 30.68
Want to track 3759 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

3759 trading today higher at 29.22 HKD, an increase of 6.4093% from yesterday's close, completing a monthly increase of 57.9459% or 10.72 HKD. Over the past 12 months, 3759 stock gained 49.1577%.
3759 pays dividends to its shareholders, with the most recent payment made on Aug 07, 2026. The next estimated payment will be in In 11 months on Aug 07, 2027 for a total of 0.22993 HKD.
The last earnings report, released on Apr 25, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.1048%, based on the last three reports.
Pharmaron Beijing Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jul 18, 2023.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

3759 Chart

Pharmaron Beijing Co., Ltd. (3759) FAQ

What is the stock price today?

The current price is 29.22 HKD.

On which exchange is it traded?

Pharmaron Beijing Co., Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 3759.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.09%.

What is its market cap?

As of today, no market cap data is available.

Has Pharmaron Beijing Co., Ltd. ever had a stock split?

Pharmaron Beijing Co., Ltd. had 2 splits and the recent split was on Jul 18, 2023.

Pharmaron Beijing Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Ian McGavney CEO
HKEX Exchange
CNE100003PG4 ISIN
CA Country
21,370 Employees
7 Jul 2026 Last Dividend
18 Jul 2023 Last Split
- IPO Date

Overview

Colibri Resource Corporation is a dedicated mineral exploration company that focuses on identifying, acquiring, exploring, and developing mineral properties, with a significant emphasis on gold deposits in Mexico. The company is strategically positioned within the Caborca Gold Belt in northwestern Sonora, emphasizing its commitment to exploring and potentially exploiting the rich mineral resources in this region. Operating from its base in Dieppe, Canada, Colibri Resource Corporation seeks to leverage the rich mineral potential of its flagship property, the Evelyn-Plomo (EP) Gold Project, which spans approximately an area of 4,766 hectares. Through its dedicated exploration efforts, Colibri aims to contribute significantly to the gold mining sector, emphasizing sustainable and responsible mining practices.

Products and Services

  • Mineral Exploration

    Specializing in the discovery and assessment of mineral properties, Colibri Resource Corporation deploys cutting-edge exploration techniques and methodologies. The primary focus is on uncovering viable gold deposits, aligning with the company's strategic direction and expertise in the precious metals sector.

  • Evelyn-Plomo (EP) Gold Project

    This flagship project embodies the core of Colibri's exploration activities. Spread over an area of 4,766 hectares within the prolific Caborca Gold Belt of northwestern Sonora, the EP Gold Project represents a significant venture in the search for new gold discoveries. Colibri Resource Corporation is committed to extensive exploration programs on this property, aiming to determine the economic viability and potential of gold production from this area.

Contact Information

Address: 105 Englehart Street
Phone: 506 383 4274